These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8288678)

  • 21. The 13th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2010).
    Lai CH; Chao A; Amant F; Vergote I
    Gynecol Oncol; 2011 Jan; 120(1):3-4. PubMed ID: 21174370
    [No Abstract]   [Full Text] [Related]  

  • 22. [Molecular targeting therapy for gynecologic cancer].
    Hatae M; Nakamura T; Onishi Y; Yamamoto F
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):233-237. PubMed ID: 18372513
    [No Abstract]   [Full Text] [Related]  

  • 23. [Individualized systemic gynecologic tumor therapy in gynecology].
    Schmidt-Matthiesen H; Schnürch HG
    Gynakologe; 1988 Dec; 21(4):319-22. PubMed ID: 3061893
    [No Abstract]   [Full Text] [Related]  

  • 24. [Synopsis of the third national seminar on chemotherapy for gynecological malignancies].
    Yang JX
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):564-5. PubMed ID: 23141173
    [No Abstract]   [Full Text] [Related]  

  • 25. [A model for gynecologic tumor therapy].
    Brody S; Gemzell C
    Lakartidningen; 1969 Jul; 66(27):2751-4. PubMed ID: 5804633
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy for gynecologic cancers.
    Rahaman J; Steiner N; Hayes MP; Chuang L; Fishman D; Gretz Iii H
    Mt Sinai J Med; 2009 Dec; 76(6):577-88. PubMed ID: 20014427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Trends in comprehensive treatment for gynecologic malignancies].
    Yakushiji M; Fujiyoshi K; Komai K; Imamura K
    Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():145-56. PubMed ID: 10410669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future directions in gynecologic cancer.
    Alberts DS
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):125-8. PubMed ID: 10348271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Key problems of chemotherapy for gynecological malignancies].
    Tan XJ; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):561-3. PubMed ID: 23141172
    [No Abstract]   [Full Text] [Related]  

  • 30. Report on NRG Oncology and the GOG Foundation.
    Alvarez RD
    Gynecol Oncol; 2016 Mar; 140(3):381-2. PubMed ID: 26905435
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeted therapies in gynecologic cancers and melanoma.
    Ortega E; Marti RM; Yeramian A; Sorolla A; Dolcet X; Llobet D; Abal L; Santacana M; Pallares J; Llombart-Cussac A; Matias-Guiu X
    Semin Diagn Pathol; 2008 Nov; 25(4):262-73. PubMed ID: 19013892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for gynecologic malignancies at Siriraj Hospital, Bangkok.
    Senapad S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):656-9. PubMed ID: 3939044
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemotherapy and gynecologic malignancy. 2.
    Decker DG; Mussey E; Malkasian GD; Johnson CE
    Postgrad Med; 1967 Apr; 41(4):393-8. PubMed ID: 6042372
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy and gynecologic malignancy. 1.
    Decker DG; Mussey E; Malkasian GD; Johnson CE
    Postgrad Med; 1967 Mar; 41(3):310-4. PubMed ID: 6019183
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemotherapy of malignant gynecologic tumors].
    Ruff H
    J Gynecol Obstet Biol Reprod (Paris); 1976 Mar; 5(2):297-9. PubMed ID: 993570
    [No Abstract]   [Full Text] [Related]  

  • 36. Meeting highlights: International Gynecologic Cancer Society (IGCS 2012).
    Eiriksson L; Reade CJ; Elit L
    Gynecol Oncol; 2013 Jan; 128(1):12-4. PubMed ID: 23397599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The beneficial effect of human urinary colony-stimulating factor (P-100) on recovery from granulocytopenia after anti-cancer chemotherapy for gynecologic cancer].
    Kasamatsu T; Tsunematsu R; Ueda K; Miyagawa N; Kawana T; Kawagoe K; Takizawa K; Takaku F; Mizuno M; Yoshikawa H
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1551-9. PubMed ID: 3053944
    [No Abstract]   [Full Text] [Related]  

  • 38. Descriptions in the peer-reviewed literature of the results of phase 2 chemotherapy trials involving gynecologic malignancies: a call for greater objectivity.
    Markman M
    Gynecol Oncol; 2006 Sep; 102(3):419-20. PubMed ID: 16814850
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination chemotherapy in clinical practice: recent applications to gynecologic cancers.
    Wade ME; Williams HM
    Conn Med; 1967 Jun; 30(6):426-9. PubMed ID: 6046075
    [No Abstract]   [Full Text] [Related]  

  • 40. Next generation sequencing for gynecologic malignancy: Promise and potential pitfalls.
    Hinchcliff EM; Westin SN
    Gynecol Oncol; 2021 Nov; 163(2):217-219. PubMed ID: 34756289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.